FR
ENContents
What is a mast cell tumor?
Mast cells are immune system cells that contain granules of histamine and other inflammatory mediators. When these cells become malignant, they form a tumor capable of invading local tissue and suddenly releasing their granules, causing severe inflammatory effects: local swelling, gastric ulcers, or even anaphylactic shock.
MCTs account for 16 to 21% of all cutaneous tumors diagnosed in dogs. They are the most common skin cancer in dogs and can occur at any age, but predominantly affect adult and senior dogs.
- Handling the mass can trigger histamine release and cause sudden localized swelling (Darier's sign)
- Gastrointestinal ulcers: histamine stimulates gastric acid secretion
- Potential anaphylactic reaction if the tumor degrades or is handled roughly
- This is why antihistamines and antacids are always part of the standard supportive treatment
Predisposed breeds
All breeds can develop an MCT. The absence of a predisposed breed does not rule out the diagnosis.
Where do they develop?
Signs and symptoms: three stages
The particular challenge of MCTs is that their appearance can be deceptive: a seemingly benign-looking skin mass can be a grade III aggressive tumor. Systemic symptoms (related to histamine) are often the first warning signs.
Never massage, squeeze, or manipulate a suspicious skin mass before consulting a veterinarian. Rough handling of an MCT can trigger histamine release and cause a serious reaction.
- Skin mass: may resemble a button, cyst, or lipoma
- Slight redness or irritation around the mass
- Loss of appetite, mild nausea (histamine effect)
- Mild fatigue, reduced enthusiasm
- Discreet gastric ulcers (occasional vomiting)
- Mass that grows, changes size, or fluctuates (swells / shrinks)
- Marked redness, warmth, ulceration around the mass
- Frequent vomiting, diarrhea, dark stools (melena)
- Noticeable weight loss
- Cough or respiratory difficulties if thoracic metastases
- Withdrawal, excessive licking of the mass
- Subcutaneous hemorrhages (bruising without trauma)
- Multiple masses appearing rapidly
- Skin ulcers around the mass, impossible wound healing
- Collapse or prostration
- Distended abdomen (possible effusion)
- Whimpering, extreme restlessness
Situations requiring immediate veterinary care
MCTs can cause medical crises from massive histamine release or rapid tumor progression.
Heavy panting, noisy breathing. May indicate thoracic metastasis or anaphylactic reaction.
Cyanosis: sign of oxygen deprivation. Absolute emergency. Call immediately.
Unable to stand, complete prostration. May indicate anaphylactic shock or visceral metastasis.
May indicate severe gastrointestinal ulcers from histamine release.
Persistent whimpering, crying, unable to get comfortable. Dog no longer tolerates any contact.
If your dog shows any of these signs, do not wait: contact your veterinarian or an emergency clinic immediately.
Diagnosis and grading system
The histological grade is the most important piece of information for planning MCT treatment. It can only be determined by biopsy or complete mass excision.
The grading system: what it means in practice
Well-differentiated tumor, locally contained. Surgery with clean margins is often curative. Very low metastasis risk.
Variable behavior: some act like grade I, others like grade III. Complete biopsy (not just cytology) is essential. May require surgery + radiation.
Poorly differentiated, rapid growth, high metastatic potential. Targeted chemotherapy (tyrosine kinase inhibitors) recommended in addition to surgery.
- Sampling a few cells from the mass with a fine needle
- Confirms the presence of mast cells
- Does NOT give the grade: insufficient to plan treatment
- Histopathological analysis: determines grade (I, II, or III)
- Evaluates surgical margins
- Essential for any treatment decision
- Chest X-rays: screening for pulmonary metastases
- Abdominal ultrasound: spleen, liver, abdominal lymph nodes
- Regional lymph node aspiration
- Complete blood panel
- Test for activating c-KIT receptor mutation (CD117)
- Predicts response to tyrosine kinase inhibitors (toceranib, masitinib)
- Recommended for grades II-III before targeted chemotherapy
Approximately 30% of canine MCTs have an activating c-KIT receptor mutation. These tumors respond particularly well to tyrosine kinase inhibitors (Palladia / toceranib).
Treatment options
Treatment is directly guided by the tumor grade, extent of disease, and the dog's overall health. Approaches can be combined for optimal outcomes.
Wide surgical excision with safety margins is the first step for almost all cases. For grade I with clean margins, surgery alone can be curative.
- Grades I and II well-localized: often curative with clean margins
- Incomplete margins: adjuvant radiation recommended
- Visceral tumors (spleen): splenectomy if indicated
Indicated after incomplete surgery (insufficient margins) or for grades II-III. Significantly reduces local recurrence risk.
- Improves local control after surgery
- Can double survival time for grade II with incomplete margins
- Available at specialized centers
Toceranib (Palladia) and masitinib (Kinavet) are oral drugs targeting specific receptors on tumor cells. Particularly effective for tumors with c-KIT mutation.
- Oral administration at home (toceranib: 3×/week)
- Effective even without c-KIT mutation in some cases
- Manageable side effects: diarrhea, fatigue, decreased appetite
- Regular blood monitoring required during treatment
Vinblastine + prednisone protocols for grades II-III, MCTs with metastases, or when TKIs fail.
- Vinblastine + prednisone: reference protocol for grades II-III
- Can be combined with TKIs in some protocols
- Administered at the clinic by IV
Essential regardless of grade: histamine effect control, pain management, nutritional support.
- Antihistamines (diphenhydramine): control of local histamine effects
- Antacids (famotidine, omeprazole): prevention of gastric ulcers
- Corticosteroids (prednisone): reduction of tumor inflammation
- Anti-nausea medication, analgesics as needed
Prognosis by grade
Grade is the most important prognostic factor. Early detection and excision of an MCT, before it progresses to a higher grade or metastasizes, remains the best strategy.
Excellent prognosis. Surgery alone is curative in the vast majority of cases. Annual follow-up recommended.
Variable prognosis depending on margins and tumor biology. Surgery + radiation ± chemotherapy. Close monitoring.
Guarded prognosis. Multimodal treatment (surgery + TKIs ± chemotherapy). Tyrosine kinase inhibitors have significantly changed the prognosis for these cases.
Tyrosine kinase inhibitors (toceranib / masitinib) have transformed the management of grade III MCTs. Dogs with metastases can today live 9 to 18 months with good quality of life under treatment.
Other factors that influence prognosis
Improving your dog's daily life
Whether treatment is curative or palliative, several daily adjustments help maintain quality of life and monitor disease progression.
- Elevated bowls if bending is difficult
- Soft or moistened food if nausea is frequent
- Regular measured meals (monitor appetite)
- Convalescence diet if significant weight loss
- Antihistamines: respect prescribed dose and schedule
- Antacids: give before meals if prescribed
- Tyrosine kinase inhibitors: follow protocol (usually 3×/week)
- Never stop prednisone abruptly without veterinary advice
- Inspect the dog's skin weekly: new masses, size changes
- Monitor stools (black stools = melena: sign of GI bleeding)
- Weigh twice a week
- Keep a follow-up journal for check-up appointments
- Do not massage, squeeze, or manipulate skin masses
- Prevent the dog from licking or scratching the mass (e-collar if needed)
- Wear gloves when caring for ulcerated masses
- Short regular walks based on tolerance
- Avoid intense activity if the dog is tired
- Ramps or steps to avoid jumping if painful
- Quiet, comfortable resting area without drafts
- Non-slip mats if the dog is weakened
- Reduce stress (children, noise, other animals)
- ×Handling, squeezing, or massaging a skin mass (risk of histamine release)
- ×Letting the dog lick or scratch the mass without protection
- ×Stopping medications abruptly (especially corticosteroids)
- ×Waiting more than 24 h if new masses appear rapidly
- ×Hard bones or toys if the dog has secondary oral ulcers
Frequently asked questions
Did you find a lump on your dog?
Don't wait. Any persistent skin mass deserves a veterinary evaluation. Early diagnosis can make all the difference for prognosis.
This guide is an informational tool for educational purposes. It does not replace a veterinary consultation. Each case of mast cell tumor is unique and requires individual evaluation. For any health concern, contact our clinic directly.